|
|
|
22.08.26 - 01:48
|
Wall Street Week | AI Hits Wages, USMCA Under Pressure, Colorado River Crisis (Bloomberg)
|
|
|
This week, Former IBM CEO Sam Palmisano discusses why companies may benefit from having a “Plan B” for AI implementation. And, AI may not be causing mass layoffs yet, but early data suggest it is already slowing wage growth in exposed occupations.
Plus, Canada may have dodged Trump's newest tariffs, but the deal could leave lasting damage to USMCA, North American manufacturing and trust between two longtime allies. Later, who pays when the Colorado River can no longer meet the West's demand?
(Source: Bloomberg)...
|
|
|
21.08.26 - 18:06
|
Leon Stok of IBM Reelected Silicon Integration Initiative Board Chair (Business Wire)
|
|
|
ROUND ROCK, Texas--(BUSINESS WIRE)--Leon Stok, vice president of Electronic Design Automation at IBM, has been reelected as board chair of the Silicon Integration Initiative for 2026-2027.
Dr. Stok has served on the Board of Si2 since 2007, previously holding several leadership roles, including prior terms as Board Chair. At IBM, he leads a team that delivers world-class design and verification flows and tools used to create some of the world's most advanced computing systems, including IBM Z and Power systems and IBM Quantum Systems.
A recognized leader in electronic design automation (EDA), Dr. Stok earned his Ph.D. from Eindhoven University in 1991. He has delivered more than 40 keynotes, invited talks, and tutorials at major IEEE and ACM conferences worldwide and at leading universities. His research contributions include over 60 published papers on topics such as high-level architectural and logic synthesis, low-power design, placement-driven synthesis, and automated schematic placement and routing....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20.08.26 - 02:24
|
Rising demand for CPO, SiPh reshapes semiconductor testing (Digitimes)
|
|
|
As chip power consumption, transmission speed and architectural complexity increase, testing has shifted from being a final pre-shipment quality gate to an earlier stage in product development and ramp-to-volume, according to KPMG managing director Jesse Chen, who previously worked at IBM and in venture capital. That shift is making testing a critical factor in product verification, yield ramp and supply chain stability....
|
|
|
|
|
|
|
18.08.26 - 16:06
|
Trustate Lands Zack Scott as CTO Amid Rapid Expansion Into New Markets (Business Wire)
|
|
|
TAMPA, Fla.--(BUSINESS WIRE)--Trustate, the leading end-to-end estate operations platform for legal and financial professionals, today announced the appointment of Zack Scott as Chief Technology Officer. A seasoned technology leader with deep expertise in AI, data integration, and enterprise-scale systems, Scott joins Trustate at a pivotal moment as the company expands beyond trusts and estates into broader legal and financial markets.
Scott most recently served as Director of Product and Customer Integration at Edgility, where he played a key leadership role in scaling the company's AI-powered healthcare technology platform. He was instrumental in Edgility's successful acquisition by ABOUT Healthcare, a transaction that combined advanced predictive analytics with care orchestration infrastructure to create a powerful, enterprise-grade solution across the patient journey.
Prior to Edgility, Scott held leadership roles at IBM Watson Health, where he led strategic advisory and integration initiatives for ...
|
|
|
18.08.26 - 13:06
|
Abcuro Announces $66 Million Series D Financing to Advance Its First-In-Class Medicine in Development for Inclusion Body Myositis (Business Wire)
|
|
|
Proceeds to support a potentially registrational clinical study in less severe inclusion body myositis (IBM) patients expected to begin in Q4 2026 and report top line results in 2H 2028
Ulviprubart showed a trend toward clinically meaningful slowing of disease progression in patients with less severe IBM in the previous Phase 2/3 MUSCLE study
Series D financing led by New Leaf Venture Partners, joined by Abcuro's existing investors and new investor Rock Springs Capital
NEWTON, Mass.--(BUSINESS WIRE)--Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases through precise modulation of cytotoxic T cells, today announced the closing of a $66 million Series D financing led by current investor New Leaf Venture Partners with participation of existing investors including funds managed by abrdn Inc., Bain Capital Life Sciences, Samsara BioCapital, Redmile Group, Mass General Brigham Ventures, RA Capital Management, Pontifax, Sanofi Ventures, Foresite Ca...
|
|
|
|
|
17.08.26 - 16:00
|
IBM’s Strengths Are The Reason to Buy Today at $234 (24/7 Wall St.)
|
|
|
IBM just posted its worst mainframe quarter in years, a securities fraud inquiry is hanging over management, and the stock sits nearly 20% below its 52-week high. So why are the franchise's most important growth signals pointing in exactly the opposite direction?...
|
|
|
|
|
|
|
|
|
14.08.26 - 15:24
|
Das Nerdquiz rund um den IBM-PC (Heise)
|
|
|
Der IBM PC 5150 ist 45 Jahre alt geworden. Was als billige Antwort auf Apple, Commodore & Co. gedacht war, wurde schnell zum Standard-PC. Dazu ein Quiz....
|
|
|
13.08.26 - 22:39
|
AGAPE-1 Technology Enters Fundraising Agreement with Castle Placement LLC to Raise Up to $8 Million (Business Wire)
|
|
|
SAN JOSE, Calif.--(BUSINESS WIRE)--AGAPE-1 Technology Inc. (“Agape-1”), a Silicon Valley based Artificial Intelligence (AI) company with autonomous security robots and drone prototypes, has engaged Castle Placement LLC, a Wall Street firm, to raise $5–$8 million for the commercialization of Agape-1's AI security robotics.
Agape-1 business operates in both the San Francisco Bay Area and Los Angeles region, to market its proprietary CDDS platform, an autonomous AI security system for surveillance and threat detection supported by its 110 U.S. patents filed, and to build its UAV assembly.
Leveraging on its AI technology, Agape-1 plans to use this capital injection to build its U.S. production for sales, and to position itself becoming a defense subcontractor with its four retired generals as military advisor /mentor.
“We are pleased to work with Castle Placement LLC as we advance Agape-1's growth,” said Howard Ho, PhD (Yale University, and a former IBM leader), Acting CEO. “This capital will ac...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
